Viewpoint: Economic evaluation of package of care interventions employing clinical guidelines

被引:9
|
作者
Barasa, Edwine W. [1 ,2 ]
English, Mike [1 ,2 ,3 ]
机构
[1] KEMRI Ctr Geog Med Res Coast, Nairobi, Kenya
[2] Wellcome Trust Res Programme, Nairobi, Kenya
[3] Univ Oxford, Dept Pediat, Oxford, England
基金
英国惠康基金;
关键词
economic evaluation; cost effectiveness analysis; complex interventions; health care evaluation; package of care; clinical practice guidelines; evaluation economique; analyse cout-efficacite; interventions complexes; evaluation des soins de sante; ensemble des soins; directives de la pratique clinique; evaluacion economica; analisis de coste-efectividad; intervenciones complejas; evaluacion de cuidados sanitarios; paquete de cuidados sanitarios; guias de practicas clinicas; MILLENNIUM DEVELOPMENT GOALS; COST-EFFECTIVENESS ANALYSIS; CHILDHOOD ILLNESS STRATEGY; QUALITY-OF-CARE; INTEGRATED MANAGEMENT; HEALTH-CARE; IMPLEMENTATION STRATEGIES; COMPLEX INTERVENTIONS; ADHERENCE; SURVIVAL;
D O I
10.1111/j.1365-3156.2010.02637.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Increasingly attention is shifting towards delivering essential packages of care, often based on clinical practice guidelines, as a means to improve maternal, child and newborn survival in low-income settings. Cost effectiveness analysis (CEA), allied to the evaluation of less complex intervention, has become an increasingly important tool for priority setting. Arguably such analyses should be extended to inform decisions around the deployment of more complex interventions. In the discussion, we illustrate some of the challenges facing the extension of CEA to this area. We suggest that there are both practical and methodological challenges to overcome when conducting economic evaluation for packages of care interventions that incorporate clinical guidelines. Some might be overcome by developing specific guidance on approaches, for example clarity in identifying relevant costs. Some require consensus on methods. The greatest challenge, however, lies in how to incorporate, as measures of effectiveness, process measures of service quality. Questions on which measures to use, how multiple measures might be combined, how improvements in one area might be compared with those in another and what value is associated with improvement in health worker practices are yet to be answered.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 50 条
  • [41] Economic evaluation is essential in healthcare for the elderly - A viewpoint
    Leidl, R
    Stratmann, D
    DRUGS & AGING, 1998, 13 (04) : 255 - 262
  • [42] Economic Evaluation is Essential in Healthcare for the ElderlyA Viewpoint
    Reiner Leidl
    Diana Stratmann
    Drugs & Aging, 1998, 13 : 255 - 262
  • [43] Controversial Issues in Economic Evaluation (I): Perspective and Costs of Health Care Interventions
    Oliva, Juan
    Brosa, Max
    Espin, Jaime
    Figueras, Montserrat
    Trapero, Marta
    REVISTA ESPANOLA DE SALUD PUBLICA, 2015, 89 (01): : 5 - 14
  • [44] Economic Evaluation of Digital Health Interventions in Palliative Care: A Systematic Review of the Literature
    Naoum, Panagiota
    Pavi, Elpida
    Athanasakis, Kostas
    FRONTIERS IN DIGITAL HEALTH, 2021, 3
  • [46] Controversial Issues in Economic Evaluation (II): Health Outcomes of Health Care Interventions
    Trapero-Bertran, Marta
    Brosa Riestra, Max
    Espin Balbino, Jaime
    Oliva, Juan
    REVISTA ESPANOLA DE SALUD PUBLICA, 2015, 89 (02): : 125 - 135
  • [47] Controversial Issues in Economic Evaluation (III): Health Care Interventions in Special Situations
    Espin Balbino, Jaime
    Brosa Riestra, Max
    Oliva Moreno, Juan
    Trapero-Bertran, Marta
    REVISTA ESPANOLA DE SALUD PUBLICA, 2015, 89 (03): : 237 - 247
  • [48] The Ethical Foundations of Nutritional Care: A viewpoint on the recent ESPEN guidelines
    Cardenas, Diana
    Pelluchon, Corine
    CLINICAL NUTRITION, 2016, 35 (06) : 1587 - 1588
  • [49] Economic analysis of health care interventions
    Konski, Andre
    SEMINARS IN RADIATION ONCOLOGY, 2008, 18 (03) : 168 - 174
  • [50] Evaluation of clinical pharmacist's interventions in an intensive care setting.
    Al-Agil, A
    Al-Jazairi, AS
    Asiri, YA
    Al-Kholi, T
    Akhras, N
    Horanieh, B
    PHARMACOTHERAPY, 2003, 23 (03): : 421 - 421